StockNews.AI
ONMD
StockNews.AI
162 days

31 Million Patient Journeys, One Mission

1. OneMedNet partners with Datavant to enhance real-world data access. 2. Collaboration leverages patient network for innovative medical research. 3. Integration boosts data visibility and aids in treatment acceleration. 4. OneMedNet leads in AI-driven data solutions for healthcare innovation. 5. Forward-looking statements reveal potential growth opportunities for ONMD.

7m saved
Insight
Article

FAQ

Why Bullish?

The partnership is likely to enhance OneMedNet's value through improved data offerings, similar to past collaborations that have led to stock price surges in other healthcare data firms.

How important is it?

The collaboration directly enhances OneMedNet's market position and potential for revenue growth, making it a significant driver for stock movements.

Why Long Term?

The impact of advancements in real-world data integration could take time to translate into financial performance and stock price appreciation, as seen with companies like Cerner after similar strategic partnerships.

Related Companies

OneMedNet joins Datavant’s Real-World data ecosystem to Power Next-Gen Healthcare March 10, 2025 08:35 ET  | Source: OneMedNet Corporation MINNEAPOLIS, March 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet, an AI-powered Real World Data leader, has announced a collaboration with Datavant, a health data platform, to provide access to tokenized, purpose-built data for life sciences and medical research through Datavant’s health data ecosystem. Leveraging OneMedNet’s network of 31M patients, 121M+ clinical studies—EMR insights like images, ECGs, and notes—this collaboration enables life sciences companies to integrate claims data for a full view of patient journeys tailored to specific diseases. By integrating OneMedNet’s patient tokens into the Datavant ecosystem of more than 300 real-world data partners, customers seeking Real-World Data for specific patient populations can effortlessly discover and access it. This streamlined process enhances longitudinal data visibility and connectivity, enabling researchers and organizations to identify the precise insights they need to speed innovative treatments and drive impactful outcomes. “Linking healthcare data securely unlocks transformative potential for researchers,” said Aaron Green, OneMedNet CEO. “Cross-referencing our data with existing datasets through the Datavant ecosystem confirms its unique value, ensuring it’s additive, non-redundant and cost-effective. This collaboration highlights OneMedNet’s leadership in medical innovation through AI, robust platforms, and seamless integration—and will accelerate the ability of organizations to advance evidence-based solutions and access critical patient-level insights, all while safeguarding privacy.” About OneMedNet Corporation OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,400 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption. Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. OneMedNet Contacts: Michael Wong, VP Marketing Email: michael.wong@onemednet.com SOURCE: ONEMEDNET CORPORATION

Related News